asmbPLS-DA

asmbPLS-DA performs adaptive sparse multi-block partial least squares discriminant analysis to integrate genomics, transcriptomics, proteomics, and metabolomics data for feature selection and disease classification.


Key Features:

  • Adaptive sparse multi-block integration: Implements adaptive sparsity within a multi-block partial least squares framework to identify and integrate relevant features across genomics, transcriptomics, proteomics, and metabolomics.
  • Discriminant analysis for disease classification: Executes discriminant analysis to distinguish among multiple disease outcome groups using integrated multi-omics profiles.
  • Enhanced feature selection validated on simulation and TCGA data: Prioritizes biologically relevant biomarkers and has been evaluated using simulation datasets and TCGA (The Cancer Genome Atlas) real-world data.
  • Integration with classification algorithms: Outputs can be combined with classification methods such as linear discriminant analysis and random forest to improve subject classification.

Scientific Applications:

  • Biomarker discovery: Identifying statistically and biologically relevant biomarkers across multiple omics layers.
  • Disease classification: Stratifying patients into disease outcome groups using integrated molecular profiles.
  • Understanding molecular mechanisms: Elucidating interactions across omics layers to investigate disease pathogenesis.

Methodology:

Adaptive sparse multi-block partial least squares discriminant analysis integrates multiple omics blocks and applies adaptive sparsity to prioritize features relevant to disease outcomes; validation used simulation data and TCGA datasets, and results can be paired with linear discriminant analysis or random forest.

Topics

Details

Cost:
Free of charge
Tool Type:
library
Operating Systems:
Mac, Linux, Windows
Programming Languages:
C++, R
Added:
1/5/2024
Last Updated:
11/24/2024

Operations

Publications

Zhang R, Datta S. Adaptive Sparse Multi-Block PLS Discriminant Analysis: An Integrative Method for Identifying Key Biomarkers from Multi-Omics Data. Genes. 2023;14(5):961. doi:10.3390/genes14050961. PMID:37239321. PMCID:PMC10218045.

PMID: 37239321
Funding: - NIH: 1UL1TR000064